Edition:
United Kingdom

Clearside Biomedical Inc (CLSD.OQ)

CLSD.OQ on NASDAQ Stock Exchange Global Market

1.21USD
20 May 2019
Change (% chg)

-- (--)
Prev Close
$1.21
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
163,498
52-wk High
$15.27
52-wk Low
$0.99

About

Clearside Biomedical, Inc. is a clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye. The Company's product candidates focus on diseases affecting the retina, which is the tissue that lines the inside of the eye and is primarily responsible for vision, and the choroid,... (more)

Overall

Beta: --
Market Cap(Mil.): $45.87
Shares Outstanding(Mil.): 37.60
Dividend: --
Yield (%): --

Financials

  CLSD.OQ Industry Sector
P/E (TTM): -- 101.85 55.51
EPS (TTM): -2.52 -- --
ROI: -140.13 7.41 11.59
ROE: -159.99 7.88 16.33

Earnings vs. Estimates